Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1. Academic Article uri icon

Overview

abstract

  • Live varicella virus vaccine was administered to 10 stable human immunodeficiency virus type 1 (HIV-1)-infected children. Subjects were monitored for adverse reactions, HIV-1 plasma levels, CD4 T cell counts and immune responses. The vaccine was well-tolerated. Varicella-zoster virus-specific lymphocyte proliferative responses were detected in all subjects by 4 weeks and in 9 of 10 subjects 1 year after vaccination.

publication date

  • April 1, 2006

Research

keywords

  • Chickenpox
  • Chickenpox Vaccine
  • HIV Infections

Identity

Scopus Document Identifier

  • 33645546249

PubMed ID

  • 16567993

Additional Document Info

volume

  • 25

issue

  • 4